← Back to directory

Ralf Bützow

Researcher Next ID · RN-039243

Researcher · Biochemistry, Genetics and Molecular Biology

University of Helsinki

Helsinki, Finland

Accepting doctoral researchersFunding unknown
Works count
419
Citation count
15,599
H-index
69
i10-index
200

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Ovarian cancer diagnosis and treatment
Endometrial and Cervical Cancer Treatments
Uterine Myomas and Treatments
Cancer-related molecular mechanisms research
Cancer Genomics and Diagnostics

Publications

  • Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma

    Modern Pathology · 2020 · 10.1038/s41379-020-0501-8

  • Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma

    Modern Pathology · 2020 · 10.1038/s41379-020-0501-8

  • Shared heritability and functional enrichment across six solid cancers

    Nature Communications · 2019 · https://doi.org/10.1038/s41467-018-08054-4

  • Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

    Nature Communications · 2016 · https://doi.org/10.1038/ncomms12675

  • Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

    International Journal of Epidemiology · 2016 · 10.1093/ije/dyw207

  • Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12

    PLoS Genetics · 2016 · 10.1371/journal.pgen.1005850

  • Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

    International Journal of Epidemiology · 2016 · 10.1093/ije/dyw207

  • Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers

    Proceedings of the National Academy of Sciences · 2016 · https://doi.org/10.1073/pnas.1518752113

  • Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12

    PLoS Genetics · 2016 · 10.1371/journal.pgen.1005850

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    PLoS ONE · 2015 · https://doi.org/10.1371/journal.pone.0128106

  • Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

    Proceedings of the National Academy of Sciences · 2014 · 10.1073/pnas.1407909111

  • Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

    Proceedings of the National Academy of Sciences · 2014 · 10.1073/pnas.1407909111

  • GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

    Nature Genetics · 2013 · https://doi.org/10.1038/ng.2564

  • Characterization of Uterine Leiomyomas by Whole-Genome Sequencing

    New England Journal of Medicine · 2013 · 10.1056/nejmoa1302736

  • RAD51C is a susceptibility gene for ovarian cancer

    Human Molecular Genetics · 2011 · 10.1093/hmg/ddr229

  • RAD51C is a susceptibility gene for ovarian cancer

    Human Molecular Genetics · 2011 · 10.1093/hmg/ddr229

  • Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers

    PLoS ONE · 2010 · https://doi.org/10.1371/journal.pone.0010277

  • The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary

    Modern Pathology · 2010 · https://doi.org/10.1038/modpathol.2010.145

  • Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells

    Cancer Research · 2010 · 10.1158/0008-5472.can-10-2388

  • Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells

    Cancer Research · 2010 · 10.1158/0008-5472.can-10-2388

  • Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

    Proceedings of the National Academy of Sciences · 2008 · https://doi.org/10.1073/pnas.0801615105

  • MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

    Cancer Research · 2008 · 10.1158/0008-5472.can-08-1954

  • Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer

    Clinical Cancer Research · 2007 · 10.1158/1078-0432.ccr-06-2660

  • Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer

    Clinical Cancer Research · 2007 · 10.1158/1078-0432.ccr-06-2660

  • Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome

    International Journal of Cancer · 2006 · https://doi.org/10.1002/ijc.22446

  • Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

    Journal of Molecular Medicine · 2006 · 10.1007/s00109-006-0054-4

  • Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

    Journal of Molecular Medicine · 2006 · 10.1007/s00109-006-0054-4

  • Molecular Analysis of Familial Endometrial Carcinoma: A Manifestation of Hereditary Nonpolyposis Colorectal Cancer or a Separate Syndrome?

    Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.06.055

  • Molecular Analysis of Familial Endometrial Carcinoma: A Manifestation of Hereditary Nonpolyposis Colorectal Cancer or a Separate Syndrome?

    Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.06.055

  • Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

    Clinical Cancer Research · 2004 · 10.1158/1078-0432.ccr-1029-3

  • Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.

    PubMed · 2003

  • Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.

    PubMed · 2003

  • The Clinical Features of Ovarian Cancer in Hereditary Nonpolyposis Colorectal Cancer

    Gynecologic Oncology · 2001 · https://doi.org/10.1006/gyno.2001.6279

  • Transcription Factors GATA-4 and GATA-6 and a GATA Family Cofactor, FOG-2, Are Expressed in Human Ovary and Sex Cord-Derived Ovarian Tumors*

    The Journal of Clinical Endocrinology & Metabolism · 2000 · 10.1210/jcem.85.9.6828

  • Transcription Factors GATA-4 and GATA-6 and a GATA Family Cofactor, FOG-2, Are Expressed in Human Ovary and Sex Cord-Derived Ovarian Tumors*

    The Journal of Clinical Endocrinology & Metabolism · 2000 · 10.1210/jcem.85.9.6828

  • LKB1 Somatic Mutations in Sporadic Tumors

    American Journal Of Pathology · 1999 · 10.1016/s0002-9440(10)65314-x

  • Human Growth Differentiation Factor 9 (GDF-9) and Its Novel Homolog GDF-9B Are Expressed in Oocytes during Early Folliculogenesis1

    The Journal of Clinical Endocrinology & Metabolism · 1999 · 10.1210/jcem.84.8.5921

  • LKB1 Somatic Mutations in Sporadic Tumors

    American Journal Of Pathology · 1999 · 10.1016/s0002-9440(10)65314-x

Current projects

    No projects listed.